1. Home
  2. SPCE vs BNR Comparison

SPCE vs BNR Comparison

Compare SPCE & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

HOLD

Current Price

$2.50

Market Cap

207.3M

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$16.01

Market Cap

252.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCE
BNR
Founded
2017
2014
Country
United States
China
Employees
N/A
N/A
Industry
Transportation Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.3M
252.7M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
SPCE
BNR
Price
$2.50
$16.01
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$3.86
N/A
AVG Volume (30 Days)
1.5M
13.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,036,000.00
N/A
Revenue This Year
N/A
$136.32
Revenue Next Year
$2,528.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.47
N/A
52 Week Low
$2.18
$2.18
52 Week High
$5.59
$41.72

Technical Indicators

Market Signals
Indicator
SPCE
BNR
Relative Strength Index (RSI) 39.29 29.59
Support Level $2.37 $15.64
Resistance Level $2.67 $24.23
Average True Range (ATR) 0.11 2.12
MACD 0.01 -0.58
Stochastic Oscillator 17.31 9.65

Price Performance

Historical Comparison
SPCE
BNR

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: